Therapeutic administration of a selective inhibitor of nitric oxide synthase does not ameliorate the chronic inflammation and tissue damage associated with adjuvant-induced arthritis in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 2, 1998, Pages 714-721

  Fletcher, Daniel S ^a   Widmer, W Richard ^a,b   Luell, Silvi ^a   Christen, Amy ^a   Orevillo, Chad ^a   Shah, Shrenik ^a   Visco, Denise ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; LYSINE DERIVATIVE; N IMINOETHYLLYSINE; NITRATE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOBLOTTING; NONHUMAN; ORAL DRUG ADMINISTRATION; PAW EDEMA; PRIORITY JOURNAL; PROPHYLAXIS; RAT; SPLEEN;

EID: 0031886450     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Adams HR (1996) Physiologic, pathophysiologic, and therapeutic implications for endogenous nitric oxide. J Am Vet Med Assoc 209:1297-1302.
2. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC and Gregory SA (1996) Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 97:2672-2679.
3. Benslay DN and Nickander R (1982) Comparative effects of benoxaprofen and other anti-inflammatory drugs on bone damage in the adjuvant arthritic rat. Agents Actions 12:313-319.
4. Burstein NA and Waksman BH (1964) The pathogenesis of adjuvant disease in the rat. 1. A histological study of early lesions in the joints and skin. Yale J Biol Med 37:177-194.
5. Cannon GW, Scott JO, Hibbs JB Jr, Hoidal JR, Huecksteadt TP and Griffiths MM (1996) Nitric oxide production during adjuvant-induced and collagen-induced arthritis. Arthritis Rheum 39:1677-1684.
6. Chang Y-H, Pearson CM and Abe C (1980) Adjuvant polyarthritis. IV. Induction by a synthetic adjuvant: Immunologic, histopathologic, and other studies. Arthritis Rheum 23:62-71.
7. Clark RL, Cuttino JT, Anderle SK, Cromartie WJ and Schwab JH (1979) Radiological analysis of arthritis in rats after systemic injection of streptococcal cell walls. Arthritis Rheum 22:25-35.
8. Connor JR, Manning PT, Settle SL, Moore WM, Jerome GM, Webber RK, Tjoeng FS and Currie MG (1995) Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur J Pharmacol 273:15-24.
9. Corbett JA, Lancaster JR Jr, Sweetland MA and McDaniel ML (1991) Interleukin-1β-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. J Biol Chem 266:21351-21354.
10. Evans CH, Stefanovic-Racic M and Lancaster J (1995) Nitric oxide and its role in orthopaedic disease. Clin Orthop Relat Res 312:275-294.
11. Farrell AJ, Blake DR, Palmer RMJ and Moncada S (1992) Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51:1219-122,.
12. Florquin S, Amraoui Z, Dubois C, Decuyper J and Goldman M (1994) The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice. J Exp Med 180:1153-1158.
13. Ialenti A, Ianaro A, Moncada S and Di Rosa M (1992) Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 211:177-182.
14. Ialenti A, Moncada S and Di Rosa M (1993) Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol 110:701-706.
15. Jacob T, Morrell M, Manzi S, Verdile V, Simmons RL and Peitzman A (1992) Elevated nitrates in inflammatory joint disease: Nitric oxide in the arthritides. Arthritis Rheum 35: R9.
16. Kaur H and Halliwell B (1994) Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 350:9-12.
17. Kwon NS, Nathan CF, Gilker C, Griffith OW, Matthews DE and Stuehr DJ (1990) L-citrulline production from L-arginine by macrophage nitric oxide synthase. J Biol Chem 265:13442-13445.
18. Langrehr JM, Murase N, Markus PM, Cai X, Neuhaus P, Schraut W, Simmons RL and Hoffman RA (1992) Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. J Clin Invest 90:679-683.
19. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie Q-W, Sokol K, Hutchinson N, Chen H and Mudgett JS (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650.
20. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie Q-W, Nathan CF and Wahl SM (1993) Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 178:749-754.
21. Miller MJS, Sadowska-Krowicka H, Chotinaruemol S, Kakkis JL and Clark DA (1993) Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther 264:11-16.
22. Misko TP, Schilling RJ, Salvemini D, Moore WM and Currie MG (1993) A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 214:11-16.
23. Moncada S, Palmer RM and Higgs EA (1991) Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142.
24. Muir VY and Dumonde DC (1982) Different strains of rats develop different clinical forms of adjuvant disease. Ann Rheum Dis 41:538-543.
25. 6-(1-iminoethyl)lysine: A selective inhibitor of inducible nitric oxide synthase. J Med Chem 37:3886-3888.
26. Pearson CM (1963) Experimental joint disease. Observations on adjuvant-induced arthritis. J Chronic Dis 16:863-874.
27. Rachmilewitz D, Karmeli F, Okon E and Bursztyn M (1995) Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 37:247-255.
28. Ribbons KA, Currie MG, Connor JR, Manning PT, Allen PC, Didier P, Ratterree MS, Clark DA and Miller MJS (1997) The effect of inhibitors of inducible nitric oxide synthase on chronic colitis in the rhesus monkey. J Pharmacol Exp Ther 280: 1008-1015.
29. Robertson CA, Green BG, Niedzwiecki L, Harrison RK and Grant SK (1993) Effect of nitric oxide synthase substrate analog inhibitors on rat liver arginase. Biochem Biophys Res Commun 197:523-528.
30. Salvemini D, Misko TP, Masferrer JL, Seibert K, Curri, MG and Needleman (1993) Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90:7240-7244.
31. Salvemini D, Manning PT, Zweifel BS, Seibert K, Connor J, Currie MG, Needleman P and Masferrer JL (1995) Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J Clin Invest 96:301-308.
32. Stefanovic-Racic M, Stadler J and Evans CH (1993) Nitric oxide and arthritis. Arthritis Rheum 36:1036-1044.
33. Stefanovic-Racic M, Meyers K, Meschte C, Coffey JW, Hoffman RA and Evans CH (1994) N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 37:1062-1069.
34. Stichtenoth DO, Gutzki FM, Tsikas D, Selve N, Bode-Boger SM, Boger RH and Frolich JC (1994) Increased urinary nitrate excretion in rats with adjuvant arthritis. Ann Rheum Dis 53:547-549.
35. Taurog JD, Sandberg GP and Mahowald ML (1983) The cellular basis of adjuvant arthritis. II. Characterization of the cells mediating passive transfer. Cell Immunol 80:198-204.
36. Tracey WR, Tse J and Carter G (1995) Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Ther 272:1011-1015.
37. Van Armand GC (1976) Pathway to adjuvant arthritis. Fed Proc 35:2442-2446.
38. Van De Langerijt AGM, Volsen SG, Hicks CA, Craig PJ, Billingham MEJ and Van Den Berg WB (1994) Cell migration studies in the adoptive transfer of adjuvant arthritis in the Lewis rat. Immunology 81:414-419.
39. Visco D, Widmer R, Shen F, Orevillo C, Christen A, Chan C-C, Leger S, Prasit, P, Therien M, Wang Z, Rodger I and MacIntyre E (1996) The effects of a selective cyclooxygenase-2 (COX-2) inhibitor on adjuvant-induced arthritis in the rat. Presented at the 10th International Conference on Prostaglandins and Related Compounds, p 202.
40. Watnich AS (1975) The adjuvant arthritic rat: A tool for discovering antiarthritic drugs, in Immunopharmacology (Rosenthale ME and Mansmann H Jr., eds) Spectrum, New York.
41. Wei X-q, Charles IG, Smith A, Ure J, Feng G-J, Huang F-p, Xu D, Muller W, Moncada S and Liew F-Y (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411.
42. Winder CV, Lembke LA and Stephens MD (1969) Comparative bioassay of drugs in adjuvant-induced arthritis in rats: Flufenamic acid, mefenamic acid, and phenylbutazone. Arthritis Rheum 12:472-482.
43. Yoshino S, Kinne R, Hunig T and Emmrich F (1990) The suppressive effect of an antibody to the αβ cell receptor in rat adjuvant arthritis: Studies on optimal treatment protocols. Autoimmunity 7: 255-266,.
44. Zheng YM, Schafer MK-H, Weihe E, Sheng H, Corisdeo S, Fu ZF, Koprowski H and Dietzschold B (1993) Severity of neurological signs and degree of inflammatory lesions in the brains of rats with Borna disease correlate with the induction of nitric oxide synthase. J Viral 67:5786-5791.